标题
Opportunities and challenges for anti-CD73 cancer therapy
作者
关键词
-
出版物
Immunotherapy
Volume 4, Issue 9, Pages 861-865
出版商
Future Medicine Ltd
发表日期
2012-10-10
DOI
10.2217/imt.12.83
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Host A2B Adenosine Receptors Promote Carcinoma Growth
- (2015) Sergey Ryzhov et al. NEOPLASIA
- CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
- (2014) A. Mikhailov et al. JOURNAL OF IMMUNOLOGY
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- CD73-Deficient Mice Are Resistant to Carcinogenesis
- (2012) J. Stagg et al. CANCER RESEARCH
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
- (2012) Xian-Rui Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth
- (2012) Frank T. Wen et al. OncoImmunology
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- Disarming suppressor cells to improve immunotherapy
- (2011) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Inhibition of T-Cell Proliferation by Murine Multipotent Mesenchymal Stromal Cells is Mediated by CD39 Expression and Adenosine Generation
- (2011) Christine Sattler et al. CELL TRANSPLANTATION
- Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
- (2011) Gennady G. Yegutkin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread
- (2011) Marko Salmi et al. FEBS LETTERS
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia
- (2011) E Wieten et al. LEUKEMIA
- NT5EMutations and Arterial Calcifications
- (2011) Cynthia St. Hilaire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
- (2011) Beat M. Künzli et al. Purinergic Signalling
- Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
- (2011) Felipe Saldanha-Araujo et al. Stem Cell Research
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of Purinergic Signaling in Cellular Response to γ Radiation
- (2010) Mitsutoshi Tsukimoto et al. RADIATION RESEARCH
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis
- (2009) Sunil Sheth et al. Purinergic Signalling
- Tenascin C interacts with Ecto-5′-nucleotidase (eN) and regulates adenosine generation in cancer cells
- (2007) Rafal Sadej et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now